BioTech
Areas of Potential Qualifying Activity
Qualifying R&D can arise throughout the development, testing and improvement of biotechnology products, processes and platform technologies. Common areas of potential qualifying activity include:
-
Development of new or substantially improved biological products and technologies.
-
Design and optimization of assays, formulations and experimental processes.
-
Development and testing of cell, protein, enzyme or molecular systems.
-
Process development, scale-up and improvements to production methods.
-
Improvements to stability, yield, reproducibility and product performance.
-
Testing and iterative development to resolve biological and technical uncertainties.
R&D in BioTech
Biotechnology companies frequently invest in the development and improvement of products, processes, formulations and platform technologies to enhance performance, consistency, scalability, reliability and technical capability.
This work can involve significant technical challenges where existing biological methods, materials, process conditions or development approaches cannot readily achieve the required level of efficacy, stability, reproducibility, yield or performance.
Where these challenges are addressed through systematic experimentation, testing and iterative development, the related biotechnology activity and associated expenditure may be eligible for the U.S. R&D Tax Credit.
.png)
Understand
Our specialist technical team works directly with your staff to understand how innovation takes place across the business.
Identify
We examine the technical challenges encountered, the development work undertaken and the decisions made throughout your projects.
Quantify
We work with your team to connect those activities to the relevant costs.
Substantiate
We prepare clear, robust technical and financial documentation designed to support the Research and Development Tax Credit claim.
Our Role
.png)